Fotodinámiás terápia a dermatoonkológiában

Translated title of the contribution: Photodynamic therapy in dermatooncology

Magdolna Gaál, R. Gyulai, Eszter Baltás, Róbert Kui, J. Oláh, L. Kemény

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Non-melanoma skin cancers are the most common skin tumors. Because of their frequent localization on the face and hand, aesthetic aspects of the therapeutic procedures should also be considered. Surgical excision still remains the first choice, but recently several new alternative therapies have emerged, especially for the treatment of superficial skin cancer. Photodynamic therapy has become a widely accepted therapeutic method for certain non-melanoma skin tumors. Photodynamic therapy involves the use of light to activate a photosensitizer, localized in diseased tissues. Photosensitizers are tumor-selective: their accumulation in rapidly proliferating cells and newly formed blood vessels is significantly higher than in the surrounding healthy tissues. During photodynamic therapy, cytotoxic reactive oxygen species are formed from the photosensitizer, leading to changes in subcellular pathways or apoptosis of the cells. Efficacy of the photodynamic therapy has been proven in solar keratosis, superficial basal cell carcinoma and morbus Bowen, with significantly better cosmetic outcome than that of the conventional therapeutic methods. Side effects, like erythema, crusting, serous discharge, or oedema, are usually moderate, and dissolve rapidly. The present article summarizes the authors' experiences with photodynamic treatment (212 non-melanoma skin cancer patients were treated with PDT between December 2003 and January 2006), at the Department of Dermatology and Allergology, University of Szeged, Hungary, and reviews the literature of photodynamic therapy in dermatooncology.

Original languageHungarian
Pages (from-to)2227-2233
Number of pages7
JournalOrvosi Hetilap
Volume148
Issue number47
DOIs
Publication statusPublished - Nov 25 2007

Fingerprint

Photochemotherapy
Photosensitizing Agents
Skin Neoplasms
Keratosis
Therapeutics
Neoplasms
Skin
Hungary
Basal Cell Carcinoma
Erythema
Complementary Therapies
Dermatology
Esthetics
Cosmetics
Blood Vessels
Reactive Oxygen Species
Edema
Hand
Apoptosis
Light

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Fotodinámiás terápia a dermatoonkológiában. / Gaál, Magdolna; Gyulai, R.; Baltás, Eszter; Kui, Róbert; Oláh, J.; Kemény, L.

In: Orvosi Hetilap, Vol. 148, No. 47, 25.11.2007, p. 2227-2233.

Research output: Contribution to journalArticle

Gaál, Magdolna ; Gyulai, R. ; Baltás, Eszter ; Kui, Róbert ; Oláh, J. ; Kemény, L. / Fotodinámiás terápia a dermatoonkológiában. In: Orvosi Hetilap. 2007 ; Vol. 148, No. 47. pp. 2227-2233.
@article{23ac8a7704ba4983ab4aec84b4815fb8,
title = "Fotodin{\'a}mi{\'a}s ter{\'a}pia a dermatoonkol{\'o}gi{\'a}ban",
abstract = "Non-melanoma skin cancers are the most common skin tumors. Because of their frequent localization on the face and hand, aesthetic aspects of the therapeutic procedures should also be considered. Surgical excision still remains the first choice, but recently several new alternative therapies have emerged, especially for the treatment of superficial skin cancer. Photodynamic therapy has become a widely accepted therapeutic method for certain non-melanoma skin tumors. Photodynamic therapy involves the use of light to activate a photosensitizer, localized in diseased tissues. Photosensitizers are tumor-selective: their accumulation in rapidly proliferating cells and newly formed blood vessels is significantly higher than in the surrounding healthy tissues. During photodynamic therapy, cytotoxic reactive oxygen species are formed from the photosensitizer, leading to changes in subcellular pathways or apoptosis of the cells. Efficacy of the photodynamic therapy has been proven in solar keratosis, superficial basal cell carcinoma and morbus Bowen, with significantly better cosmetic outcome than that of the conventional therapeutic methods. Side effects, like erythema, crusting, serous discharge, or oedema, are usually moderate, and dissolve rapidly. The present article summarizes the authors' experiences with photodynamic treatment (212 non-melanoma skin cancer patients were treated with PDT between December 2003 and January 2006), at the Department of Dermatology and Allergology, University of Szeged, Hungary, and reviews the literature of photodynamic therapy in dermatooncology.",
keywords = "DALA, MAL, Non-melanoma skin cancer, PDT",
author = "Magdolna Ga{\'a}l and R. Gyulai and Eszter Balt{\'a}s and R{\'o}bert Kui and J. Ol{\'a}h and L. Kem{\'e}ny",
year = "2007",
month = "11",
day = "25",
doi = "10.1556/OH.2007.28198",
language = "Hungarian",
volume = "148",
pages = "2227--2233",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "47",

}

TY - JOUR

T1 - Fotodinámiás terápia a dermatoonkológiában

AU - Gaál, Magdolna

AU - Gyulai, R.

AU - Baltás, Eszter

AU - Kui, Róbert

AU - Oláh, J.

AU - Kemény, L.

PY - 2007/11/25

Y1 - 2007/11/25

N2 - Non-melanoma skin cancers are the most common skin tumors. Because of their frequent localization on the face and hand, aesthetic aspects of the therapeutic procedures should also be considered. Surgical excision still remains the first choice, but recently several new alternative therapies have emerged, especially for the treatment of superficial skin cancer. Photodynamic therapy has become a widely accepted therapeutic method for certain non-melanoma skin tumors. Photodynamic therapy involves the use of light to activate a photosensitizer, localized in diseased tissues. Photosensitizers are tumor-selective: their accumulation in rapidly proliferating cells and newly formed blood vessels is significantly higher than in the surrounding healthy tissues. During photodynamic therapy, cytotoxic reactive oxygen species are formed from the photosensitizer, leading to changes in subcellular pathways or apoptosis of the cells. Efficacy of the photodynamic therapy has been proven in solar keratosis, superficial basal cell carcinoma and morbus Bowen, with significantly better cosmetic outcome than that of the conventional therapeutic methods. Side effects, like erythema, crusting, serous discharge, or oedema, are usually moderate, and dissolve rapidly. The present article summarizes the authors' experiences with photodynamic treatment (212 non-melanoma skin cancer patients were treated with PDT between December 2003 and January 2006), at the Department of Dermatology and Allergology, University of Szeged, Hungary, and reviews the literature of photodynamic therapy in dermatooncology.

AB - Non-melanoma skin cancers are the most common skin tumors. Because of their frequent localization on the face and hand, aesthetic aspects of the therapeutic procedures should also be considered. Surgical excision still remains the first choice, but recently several new alternative therapies have emerged, especially for the treatment of superficial skin cancer. Photodynamic therapy has become a widely accepted therapeutic method for certain non-melanoma skin tumors. Photodynamic therapy involves the use of light to activate a photosensitizer, localized in diseased tissues. Photosensitizers are tumor-selective: their accumulation in rapidly proliferating cells and newly formed blood vessels is significantly higher than in the surrounding healthy tissues. During photodynamic therapy, cytotoxic reactive oxygen species are formed from the photosensitizer, leading to changes in subcellular pathways or apoptosis of the cells. Efficacy of the photodynamic therapy has been proven in solar keratosis, superficial basal cell carcinoma and morbus Bowen, with significantly better cosmetic outcome than that of the conventional therapeutic methods. Side effects, like erythema, crusting, serous discharge, or oedema, are usually moderate, and dissolve rapidly. The present article summarizes the authors' experiences with photodynamic treatment (212 non-melanoma skin cancer patients were treated with PDT between December 2003 and January 2006), at the Department of Dermatology and Allergology, University of Szeged, Hungary, and reviews the literature of photodynamic therapy in dermatooncology.

KW - DALA

KW - MAL

KW - Non-melanoma skin cancer

KW - PDT

UR - http://www.scopus.com/inward/record.url?scp=36849010080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36849010080&partnerID=8YFLogxK

U2 - 10.1556/OH.2007.28198

DO - 10.1556/OH.2007.28198

M3 - Article

C2 - 18003581

AN - SCOPUS:36849010080

VL - 148

SP - 2227

EP - 2233

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 47

ER -